DGNOF
Price:
$0.17
Market Cap:
$25.49M
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.
Industry
Medical - Healthcare Information Services
IPO Date
2003-06-24
Stock Exchange
PNK
Ticker
DGNOF
According to DIAGNOS Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.67. This represents a change of -18.65% compared to the average of -6.97 of the last 4 quarters.
The mean historical PE Ratio of DIAGNOS Inc. over the last ten years is -4.94. The current -5.67 PE Ratio has changed 11.37% with respect to the historical average. Over the past ten years (40 quarters), DGNOF's PE Ratio was at its highest in in the December 2016 quarter at 73.19. The PE Ratio was at its lowest in in the September 2023 quarter at -18.39.
Average
-4.94
Median
-3.75
Minimum
-10.07
Maximum
-1.33
Discovering the peaks and valleys of DIAGNOS Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 374.75%
Maximum Annual PE Ratio = -1.33
Minimum Annual Increase = -63.92%
Minimum Annual PE Ratio = -10.07
Year | PE Ratio | Change |
---|---|---|
2024 | -6.42 | -31.31% |
2023 | -9.34 | 11.52% |
2022 | -8.38 | -16.85% |
2021 | -10.07 | 374.75% |
2020 | -2.12 | 44.15% |
2019 | -1.47 | -63.92% |
2018 | -4.08 | 19.18% |
2017 | -3.42 | 157.39% |
2016 | -1.33 | -52.28% |
2015 | -2.79 | -26.54% |
The current PE Ratio of DIAGNOS Inc. (DGNOF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-8.05
5-year avg
-7.27
10-year avg
-4.94
DIAGNOS Inc.’s PE Ratio is less than Cogstate Limited (20.36), less than Cognetivity Neurosciences Ltd. (-0.13), less than CareMax, Inc. (-0.00), less than Mednow Inc. (-0.01), less than DATATRAK International, Inc. (0.49),
Company | PE Ratio | Market cap |
---|---|---|
20.36 | $150.20M | |
-0.13 | $641.46K | |
-0.00 | $1.61M | |
-0.01 | $517.29K | |
0.49 | $293.94K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DIAGNOS Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like DIAGNOS Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is DIAGNOS Inc.'s PE Ratio?
How is the PE Ratio calculated for DIAGNOS Inc. (DGNOF)?
What is the highest PE Ratio for DIAGNOS Inc. (DGNOF)?
What is the 3-year average PE Ratio for DIAGNOS Inc. (DGNOF)?
What is the 5-year average PE Ratio for DIAGNOS Inc. (DGNOF)?
How does the current PE Ratio for DIAGNOS Inc. (DGNOF) compare to its historical average?